Prof. Alireza Heidari
Faculty of Chemistry
California South University (CSU), USA
Full Professor and Academic Tenure of
Chemistry
Director of the BioSpectroscopy Core
Research Laboratory
American International Standards Institute (AISI), USA
President of AISI
Emails: Scholar.Researcher.Scientist@gmail.com (preferred), Alireza.Heidari@calsu.us
Qualifications
2012 Ph.D. & D.Sc., California South University (CSU), USA, Biophysical Chemistry
2008 M.S., Islamic Azad University (IAU), Iran, Physical Chemistry
2005 B.S., Islamic Azad University (IAU), Iran, Pure Chemistry
Publications (Selected)
1. A. Heidari, C. Brown, “Study of Composition
and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer
Cells”, Journal of Nanomedicine Research, Volume 2, Issue 5, 20 Pages, 2015.
2. A. Heidari, C. Brown, “Study of Surface
Morphological, Phytochemical and Structural Characteristics of Rhodium (III)
Oxide (Rh2O3) Nanoparticles”, International Journal of Pharmacology,
Phytochemistry and Ethnomedicine, Volume 1, Pages 15–19, 2015.
3. A. Heidari, “Computational Studies on
Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and
Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”,
J Appl Computat Math 5: e142, 2016.
4. A. Heidari, “Study of Irradiations to Enhance
the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and
Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman
and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016.
5. A. Heidari, “Future Prospects of Point
Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in
Photodynamic Therapy (PDT) for Cancer Cells”, J Bioanal Biomed 8: e135, 2016.
6. A. Heidari, “Quantitative Structure–Activity
Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III)
Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of
Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation
Approach”, Ann Clin Lab Res. 4: 1, 2016.
7. A. Heidari, “Spectroscopy and Quantum
Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+),
Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium
Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016.
8. A. Heidari, “A Combined Computational and
QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous
Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes
(h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016.
9. A. Heidari, “Combined Theoretical and
Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius
Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide,
Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2,
2016.
10. A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of
Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and
Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J
Nanomedine Biotherapeutic Discov 6: e144, 2016.
11. A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for
Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol,
Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease:
A Glycobiological Study”, J Glycobiol 5: e111, 2016.
12. A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic
Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using
Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol
12: 4, 2016.
13. A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review
of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3(1): 1058,
2016.
14. A. Heidari, C. Brown, “Phase, Composition and Morphology Study and
Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
15. A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and
Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International
Journal of Advanced Chemistry, 4 (1) 5–9, 2016.
16. A. Heidari, “Linear and Non–Linear Quantitative
Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium
(IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase
Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
17. A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear
Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models
for the Prediction of Retention Time of Anti–Cancer Nano Drugs under
Synchrotron Radiations”, J Pharmacovigil 4: e161, 2016.
18. A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear
Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models
for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs
under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
19. A. Heidari, “A Successful Strategy for the Prediction of Solubility
in the Construction of Quantitative Structure–Activity Relationship (QSAR) and
Quantitative Structure–Property Relationship (QSPR) under Synchrotron
Radiations Using Genetic Function Approximation (GFA) Algorithm”, J Mol Biol
Biotechnol 1: 1, 2016.
20. A. Heidari, “Computational Study on Molecular Structures of C20, C60,
C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron
Radiations Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
21. A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene
Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and
Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes
(BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron
Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016.
22. A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship
(QSAR) and Quantitative Structure–Property Relationship (QSPR) under
Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano
Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA)
Algorithm”, Insight Pharm Res. 1: 1, 2016.
23. A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation
of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12)
Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60,
(SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and
(SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol
Nanotechnol, 6: 3, 2017.
24. A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics,
Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent
for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone
Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs 6: e154.
25. A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in
Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis
(MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84,
Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44,
Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and
Au25(pMBA)18 Nano Clusters”, J Surgery Emerg Med 1: 21, 2017.
Profile Details
http://calsu.us/index.php/member/prof-dr-alireza-heidari/